Navigation Links
FDA considers nicotine lollipops illegal

The Food and Drug Administration cracked down on Internet distributors of nicotine-laced lollipops and lip balm, declaring them illegal and ordering that 4 pharmacies stop sales immediately. The lollipops in particular pose a risk to children because they look like regular candy, the FDA warned. "The quantity of nicotine could be potentially dangerous to a small child," said FDA attorney David Horowitz. //

The agency can't say for sure if the lollipops pose an immediate health risk to adult smokers, because they are made with a different form of nicotine than is found in nicotine gum, patches or other approved products. That form of nicotine has not been tested for safety. That alone makes the lollipops and lip balm illegal to sell, but the Internet pharmacies also had been wrongly dispensing them without a doctor's prescription, the FDA said.

The FDA gave the 4 pharmacies 15 days to tell the government they're stopping sales or risk further legal action. The FDA is reviewing other unconventional nicotine products, such as a Virginia company's nicotine lozenge, to see if they also qualify as drugs being sold illegally.
'"/>




Page: 1

Related medicine news :

1. IMF considers Bird Flu to be a Dark Cloud
2. Accomplishment of nicotine replacement therapy
3. Catherine Zeta wants to give up nicotine cravings
4. Free nicotine patches to quit smoking
5. Women, be on guard against illegally procured IUDs
Post Your Comments:
Breaking Medicine News(10 mins):Health News:BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment 2Health News:Agendia to Present Broad Array of Data at 2009 San Antonio Breast Cancer Symposium 2Health News:Agendia to Present Broad Array of Data at 2009 San Antonio Breast Cancer Symposium 3Health News:Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions 2Health News:Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions 3Health News:Consumers Choose Dallas Hospital for National Award Based on Quality and Image 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 3Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 4
Other Medicine News:Health News:The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate 2Health News:The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate 3Health News:The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate 4Health News:eCardio Chief Executive Officer Larry Lawson Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Finalist in the Houston & Gulf Coast Area Program 2Health News:Entrepreneur Magazine Names American TeleCare, Inc. (ATI) One of the Nation's 100 Brilliant Companies to Watch in 10 Hot Industries 2Health News:Entrepreneur Magazine Names American TeleCare, Inc. (ATI) One of the Nation's 100 Brilliant Companies to Watch in 10 Hot Industries 3Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 2Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 3Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 4Health News:Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare 5Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 2Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 3Health News:Be a Part of the 1st World MS Day - May 27, 2009 2Health News:Be a Part of the 1st World MS Day - May 27, 2009 3Health News:Be a Part of the 1st World MS Day - May 27, 2009 4Health News:Be a Part of the 1st World MS Day - May 27, 2009 5
Breaking Medicine Technology:$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 3$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 5$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 6Roche Diagnostics Opens State-of-the-Art Training Center in California 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7Collaboration of Indianas Health Information Exchanges State Organizations Submits Application for Health Information Technology Stimulus Funding 14509 1Collaboration of Indianas Health Information Exchanges State Organizations Submits Application for Health Information Technology Stimulus Funding 14509 2Collaboration of Indianas Health Information Exchanges State Organizations Submits Application for Health Information Technology Stimulus Funding 14509 3Collaboration of Indianas Health Information Exchanges State Organizations Submits Application for Health Information Technology Stimulus Funding 14509 4Grifols Breaks Ground on New National Testing Laboratory 14506 1Grifols Breaks Ground on New National Testing Laboratory 14506 2Oxygen Biotherapeutics Inc to Webcast Shareholder Meeting 5524 1